Rockefeller Capital Management L.P. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$72
-20.9%
14,702
+0.5%
0.00%
Q4 2022$91
-99.9%
14,625
+3.8%
0.00%
-100.0%
Q3 2022$151,000
+3.4%
14,083
+9.7%
0.00%0.0%
Q2 2022$146,000
-60.4%
12,835
-68.4%
0.00%
-50.0%
Q1 2022$369,000
-24.1%
40,589
+24.3%
0.00%0.0%
Q4 2021$486,000
+89.1%
32,646
+226.5%
0.00%
+100.0%
Q3 2021$257,000
+233.8%
10,000
+227.4%
0.00%0.0%
Q4 2020$77,0003,0540.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders